GSTP1

Across TCGA pan-cancer cohorts, GSTP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GSTP1 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher GSTP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GSTP1 expression acts as an unfavorable survival marker.

BRCA, BLCA, and PRAD are the cancer types where GSTP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.300	0.924	<.001	36	view →
BLCA	DFS	Median	All	0.132	0.626	.006	12	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GSTP1–BRCA (OS)

Open the BRCA breakdown →